期刊文献+

257例重度子痫前期/子痫降压药应用现状分析

A study on application of antihypertensive drugs on 257 cases with severe preeclampsia and eclampsia
下载PDF
导出
摘要 目的探讨重度子痫前期/子痫降压药的应用情况,针对存在的问题提出改进措施。方法收集孕产妇死亡率较高的河南省某县2005年7月-2007年8月所有开展助产技术服务的医疗保健机构中重度子痫前期/子瘸住院病例,对其病历资料进行调查研究,制定降压药规范化应用基本标准,评价其服务质量,分析降压药应用与妊娠结局的关系。结果257例中仅有49.42%达到降压药规范化应用基本标准。规范化应用降压药的病例其胎盘早剥发生率(2.61%)乖低出生体重儿的比例(17.17%)显著低于未规范化应用者(9.24%、36.54%),经比较差异有统计学意义(X^2值分别为4.577和9.631,均P〈o.05)。结论该地区医务人员在规范化应用降压药治疗重度子痫前期/子痫病例中存在明显不足,服务质量有待进一步提高,以促进母婴健康。 Objective To explore the application status of antihypertensive drugs on 257 cases with severe preeclampsia and eclampsia in order to propose targeted improvements. Methods This study was conducted from July 2005 to August 2007. Medical data of pregnant patients with severe preeclampsia and eclampsia were collected from all of the hospitals where midwifery services were carried out in some county of Henan Province where the maternal mortality rate was high. The data were analyzed, and basic criterion on standard application of antihypertensive drugs was developed for evaluating its service quality. In addition, the relationship between application of antihypertensive drugs and pregnancy outcomes was explored. Results Only 127 (49.42%) of 257 cases achieved the basic standard on antihypertensive application. The incidence of placental abruption (2.61%) and the proportion of low birth weight infants ( 17.17% ) of cases with standard application of antihypertensive agents were obviously lower than those (9.24%, 36.54% ) of cases without standard application respectively, and the differences were statistically significant (X2 was 4.577 and 9.631 respectively, P 〈 O. 05 ). Conclusion In the study area there is obviously deficiency on standard application of antihypertensive drugs on severe preeclampsia and eclampsia. Quality of service should be further improved in order to promote maternal and child health.
出处 《中国妇幼健康研究》 2011年第4期496-499,共4页 Chinese Journal of Woman and Child Health Research
关键词 重度子痫前期 子痫 孕产妇 降压药 severe preeclampsia eelampsia pregnant women antihypertensive drugs
  • 相关文献

参考文献18

  • 1Sakala,Elmar P.High-yield obstetrics and gynecology[M].America:Lippincott Williams & Wilkins,2004:197-201.
  • 2Weeks A D,Alia G,Otolorin E O.A criteria-based audit of the management of severe preeclampsia in Kampala,Uganda[J].Int J Gynaecol Obstet,2005,91(3):292-297.
  • 3Perez C R,Morales H R,Doubova S V,et al.Development and use of quality of care indicators for obstetric care in women with preeclampsia,severe preeclampsia,and severe morbidity[J].Hypertens Pregnancy,2007,26(3):241-257.
  • 4Frias A E Jr,Belfort M A.Post Magpie:How should we be managing severe preeclampsia[J]?Curr Opin Obstet Gynecol,2003,15(6):489-495.
  • 5Andersgaard A B,Herbst A,Johansen M,et al.Eclampsia in Scandinavia:Incidence,substandard care,and potentially preventable cases[J].Acta Obstet Gynecol Scand,2006,85(8):929-936.
  • 6Wagaarachchi P T,Graham W J,Penney G C.Holding up a mirror:Changing obstetric practice through criterion-based clinical audit in developing countries[J].Int J Gynaecol Obstet,2001,74(2):119-130.
  • 7Okong P,Byamugisha J,Mirembe F,et al.Audit of severe maternal morbidity in Uganda-implications for quality of obstetric care[J].Acta Obstet Gynecol Scand,2006,85(7):797-804.
  • 8Sobande A A,Eskandar M,Bahar A.Severe pre-eclampsia and eclampsia in Abha,the south west region of Saudi Arabia[J].J Obstet Gynaecol,2007,27(2):150-154.
  • 9游泽山.孕产妇用药 第二讲 降压药物在孕产妇中的应用[J].新医学,2002,33(4):238-240. 被引量:2
  • 10张凤霞,王临虹,吴久玲,林晓宁,张海燕,冯胜梅,马西,闫淑兰.农村严重妊娠高血压疾病医疗状况分析[J].中国妇幼健康研究,2007,18(3):210-213. 被引量:9

二级参考文献63

  • 1吕爱荣,宋爱芹.重度妊高征妊娠结局及围生儿预后分析[J].济宁医学院学报,2006,29(1):59-59. 被引量:4
  • 2Lelia D. The gobal ipact of pe-eclampsia and elampsia [ J ]. Seminar in Perinatology, 2009,33 ( 3 ):130 -137.
  • 3Hanff L M,Visser W,Vulto A G,et al. Pharmacological management of severe pre-eclampsia [ J ]. European Clinics in Obstetrics and Gynaecology,2006,2( 1 ) :9-17.
  • 4Rhoney D, Peacock W F. Intravenous therapy for hypertensive emergencies[ J]. Am J Health Syst Pharm, 2009,66 ( 15 ) : 1343- 1352.
  • 5Varon J. Treatment of acute severe hypertension.. Current and newer agents [ J ]. Drugs, 2008,68 ( 3 ) : 283 -297.
  • 6McCoy S, Baldwin K. Pharmacotherapeutic options for the treatment of preeclampsia [ J ]. Am J Health Syst Pharm, 2009,66 ( 4 ) : 337- 344.
  • 7Lowe S A, Brown M A, Dekker G A, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008 [ J ]. Australia & New Zealand Journal of Obstetric & Gynaecology,2009, 49 ( 3 ) :242-246.
  • 8Finks S W, Finks A L, Self T H. Hydralazine-induced lupus: Maintaining vigilance with increased use in patients with heart failure [ J ]. Southern Medical Journal,2006,99 ( 1 ) : 18-22.
  • 9De Vigil G P, Ruiz E, Lopez J C, et al. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: A randomized clinical trial [ J ]. In Pregnancy, 2007,26 (2) : 163-171.
  • 10Hanff, Lidwien, Vulto, et al. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptie patients [ J ]. Journal of Hypertension, 2005,23 ( 12 ) : 2319-2326.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部